Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio
PLAINSBORO, N.J., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, in December, it closed on the acquisition of the product portfolio from Metasurg. The addition of the Metasurg product portfolio enhances Integra's lower extremity
View HTML
Toggle Summary Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business
Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the
View HTML
Toggle Summary Integra LifeSciences Acquires Rebound Therapeutics Corporation
Acquisition Adds New, Minimally Invasive Platform for Neurosurgery PLAINSBORO, N.J., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it has acquired Rebound Therapeutics, developers of
View HTML
Toggle Summary Integra LifeSciences Acquires SeaSpine
Integra Spine Doubles Its Distribution Network and Revenue Base in Spinal Hardware Kirt Stephenson Joins Integra as President, U.S. Spine PLAINSBORO, N.J., May 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired SeaSpine, Inc., a
View HTML
Toggle Summary Integra LifeSciences Acquires the Assets of Innovative Spinal Technologies, Inc.
PLAINSBORO, N.J., Sep 14, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Integra Spine has acquired substantially all of the assets of Innovative Spinal Technologies, Inc. (IST) for $9.25 million in cash.
View HTML
Toggle Summary Integra LifeSciences Acquires Theken Spine
PLAINSBORO, N.J., Aug 4, 2008 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (together "Theken") for $75 million in cash, subject to certain adjustments, and
View HTML
Toggle Summary Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System
Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System PLAINSBORO, N.J., Feb. 9, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, released its latest image registration software, ImageFusion™
View HTML
Toggle Summary Integra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation
Integra LifeSciences Agrees to Acquire Spinal Specialties from I-Flow Corporation Plainsboro, NJ / October 28, 2003 / -- Integra LifeSciences Holdings Corporation (NASDAQ: IART - news) announced today that it has agreed to acquire Spinal Specialties, Inc.
View HTML
Toggle Summary Integra LifeSciences and IsoTis to Combine Creating a Global Leader in Orthobiologics
PLAINSBORO, N.J. and IRVINE, Calif., Aug 7, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) ("Integra") and IsoTis, Inc. (Nasdaq:ISOT) ("IsoTis") announced today a definitive agreement whereby Integra would acquire IsoTis in an all cash
View HTML
Toggle Summary Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents
Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) and REVA Medical, Inc.
View HTML
Toggle Summary Integra LifeSciences and SeaSpine to Present at the Jefferies 2015 Global Healthcare Conference in June
PLAINSBORO, N.J., May 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will make the following presentations at the Jefferies 2015 Global Healthcare Conference in New York City: At 4:00PM ET on Tuesday, June 2, 2015, Mr.
View HTML
Toggle Summary Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco
Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation
View HTML
Toggle Summary Integra LifeSciences and University of Pennsylvania To Present Results of LICOX Brain Tissue Oxygen Monitoring Clinical Experience At the 2006 American Association of Neurological Surgeons -- AANS -- Annual Meeting in San Francisco
Integra LifeSciences and University of Pennsylvania To Present Results of LICOX Brain Tissue Oxygen Monitoring Clinical Experience At the 2006 American Association of Neurological Surgeons -- AANS -- Annual Meeting in San Francisco PLAINSBORO, N.J., April 25, 2006 (PRIMEZONE) -- Integra
View HTML
Toggle Summary Integra LifeSciences Announces $2.8 Million In-Kind Donation of Medical Devices to CURE International
Effort Supports Life-Changing Pediatric Surgeries in Dominican Republic, Uganda and Zambia
View HTML
Toggle Summary Integra LifeSciences Announces $4 Million In-Kind Donation of Medical Devices to FIENS
Effort Supports Neurosurgical Residencies in Developing Countries
View HTML